270 related articles for article (PubMed ID: 10204800)
1. Mechanistic studies of the effects of the retinoid N-(4-hydroxyphenyl)retinamide on prostate cancer cell growth and apoptosis.
Shen JC; Wang TT; Chang S; Hursting SD
Mol Carcinog; 1999 Mar; 24(3):160-8. PubMed ID: 10204800
[TBL] [Abstract][Full Text] [Related]
2. Modulation of cyclophilin gene expression by N-4-(hydroxyphenyl)retinamide: association with reactive oxygen species generation and apoptosis.
Hursting SD; Shen JC; Sun XY; Wang TT; Phang JM; Perkins SN
Mol Carcinog; 2002 Jan; 33(1):16-24. PubMed ID: 11807954
[TBL] [Abstract][Full Text] [Related]
3. Regulation of apoptosis induced by the retinoid N-(4-hydroxyphenyl) retinamide and effect of deregulated bcl-2.
Delia D; Aiello A; Formelli F; Fontanella E; Costa A; Miyashita T; Reed JC; Pierotti MA
Blood; 1995 Jan; 85(2):359-67. PubMed ID: 7811993
[TBL] [Abstract][Full Text] [Related]
4. Effects of fenretinide (4-HPR) on prostate LNCaP cell growth, apoptosis, and prostate-specific gene expression.
Hsieh TC; Wu JM
Prostate; 1997 Oct; 33(2):97-104. PubMed ID: 9316650
[TBL] [Abstract][Full Text] [Related]
5. Effect of N-(4-hydroxyphenyl)retinamide on apoptosis in human breast cancer cells.
Wang TT; Phang JM
Cancer Lett; 1996 Oct; 107(1):65-71. PubMed ID: 8913268
[TBL] [Abstract][Full Text] [Related]
6. c-Jun N-terminal kinase mediates apoptotic signaling induced by N-(4-hydroxyphenyl)retinamide.
Chen YR; Zhou G; Tan TH
Mol Pharmacol; 1999 Dec; 56(6):1271-9. PubMed ID: 10570055
[TBL] [Abstract][Full Text] [Related]
7. Induction of apoptosis by N-(4-hydroxyphenyl)retinamide and its association with reactive oxygen species, nuclear retinoic acid receptors, and apoptosis-related genes in human prostate carcinoma cells.
Sun SY; Yue P; Lotan R
Mol Pharmacol; 1999 Mar; 55(3):403-10. PubMed ID: 10051523
[TBL] [Abstract][Full Text] [Related]
8. The chemopreventive agent N-(4-hydroxyphenyl)retinamide induces apoptosis through a mitochondrial pathway regulated by proteins from the Bcl-2 family.
Boya P; Morales MC; Gonzalez-Polo RA; Andreau K; Gourdier I; Perfettini JL; Larochette N; Deniaud A; Baran-Marszak F; Fagard R; Feuillard J; Asumendi A; Raphael M; Pau B; Brenner C; Kroemer G
Oncogene; 2003 Sep; 22(40):6220-30. PubMed ID: 13679861
[TBL] [Abstract][Full Text] [Related]
9. p-Dodecylaminophenol derived from the synthetic retinoid, fenretinide: antitumor efficacy in vitro and in vivo against human prostate cancer and mechanism of action.
Takahashi N; Watanabe Y; Maitani Y; Yamauchi T; Higashiyama K; Ohba T
Int J Cancer; 2008 Feb; 122(3):689-98. PubMed ID: 17955489
[TBL] [Abstract][Full Text] [Related]
10. Fenretinide: induction of apoptosis and endogenous transforming growth factor beta in PC-3 prostate cancer cells.
Roberson KM; Penland SN; Padilla GM; Selvan RS; Kim CS; Fine RL; Robertson CN
Cell Growth Differ; 1997 Jan; 8(1):101-11. PubMed ID: 8993839
[TBL] [Abstract][Full Text] [Related]
11. The synthetic retinoid N-(4-hydroxyphenyl) retinamide (4-HPR) exerts antiproliferative and apoptosis-inducing effects in the androgen-independent human prostatic JCA-1 cells.
Hsieh TC; Ng C; Wu JM
Biochem Mol Biol Int; 1995 Oct; 37(3):499-506. PubMed ID: 8595390
[TBL] [Abstract][Full Text] [Related]
12. Low-dose genistein induces cyclin-dependent kinase inhibitors and G(1) cell-cycle arrest in human prostate cancer cells.
Shen JC; Klein RD; Wei Q; Guan Y; Contois JH; Wang TT; Chang S; Hursting SD
Mol Carcinog; 2000 Oct; 29(2):92-102. PubMed ID: 11074606
[TBL] [Abstract][Full Text] [Related]
13. Contributions of mitogen-activated protein kinase and nuclear factor kappa B to N-(4-hydroxyphenyl)retinamide-induced apoptosis in prostate cancer cells.
Shimada K; Nakamura M; Ishida E; Kishi M; Yonehara S; Konishi N
Mol Carcinog; 2002 Nov; 35(3):127-37. PubMed ID: 12410564
[TBL] [Abstract][Full Text] [Related]
14. [In vitro effect of zilongjin on prostate cancer cell line LNCaP].
Li XS; Liang YY; Wang DS; Xie X; Shi C; Chen J; Sun G; Zhou L; Xue Z; Na Y; Guo Y
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2004 Jul; 24(7):621-4. PubMed ID: 15307702
[TBL] [Abstract][Full Text] [Related]
15. N-(4-Hydroxyphenyl) retinamide induced both differentiation and apoptosis in human glioblastoma T98G and U87MG cells.
Das A; Banik NL; Ray SK
Brain Res; 2008 Aug; 1227():207-15. PubMed ID: 18602901
[TBL] [Abstract][Full Text] [Related]
16. Modulation of the malignant phenotype of human prostate cancer cells by N-(4-hydroxyphenyl)retinamide (4-HPR).
Webber MM; Bello-DeOcampo D; Quader S; Deocampo ND; Metcalfe WS; Sharp RM
Clin Exp Metastasis; 1999 May; 17(3):255-63. PubMed ID: 10432011
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis-related gene expression affected by a GnRH analogue without induction of programmed cell death in LNCaP cells.
Angelucci C; Iacopino F; Lama G; Capucci S; Zelano G; Boca M; Pistilli A; Sica G
Anticancer Res; 2004; 24(5A):2729-38. PubMed ID: 15517879
[TBL] [Abstract][Full Text] [Related]
18. Increase of ceramide and induction of mixed apoptosis/necrosis by N-(4-hydroxyphenyl)- retinamide in neuroblastoma cell lines.
Maurer BJ; Metelitsa LS; Seeger RC; Cabot MC; Reynolds CP
J Natl Cancer Inst; 1999 Jul; 91(13):1138-46. PubMed ID: 10393722
[TBL] [Abstract][Full Text] [Related]
19. N-(4-hydroxyphenyl)retinamide induces growth arrest and apoptosis in HTLV-I-transformed cells.
Darwiche N; Hatoum A; Dbaibo G; Kadara H; Nasr R; Abou-Lteif G; Bazzi R; Hermine O; de Thé H; Bazarbachi A
Leukemia; 2004 Mar; 18(3):607-15. PubMed ID: 14712289
[TBL] [Abstract][Full Text] [Related]
20. BBC3 mediates fenretinide-induced cell death in neuroblastoma.
Wei JS; Whiteford CC; Cenacchi N; Son CG; Khan J
Oncogene; 2005 Dec; 24(54):7976-83. PubMed ID: 16091745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]